Clusters of transmembrane residues are critical for human prostacyclin receptor activation

Biochemistry

Volumn 43, Issue 28, 2004, Pages 8974-8986

  Stitham, Jeremiah ^a   Stojanovic, Aleksandar ^a   Ross, Lauren A ^a   Blount Jr , Anthony C ^a   Hwa, John ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Dept of Pharmacology and Toxicology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGANDS; TRANSMEMBRANE RESIDUES;

BIOLOGICAL MEMBRANES; BLOOD; COAGULATION; MUSCLE; PROTEINS;

BIOCHEMISTRY;

AMINO ACID; G PROTEIN COUPLED RECEPTOR; PROSTACYCLIN RECEPTOR; PROSTANOID RECEPTOR; RHODOPSIN;

ANIMAL CELL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MOTIF; VASCULAR SMOOTH MUSCLE;

AMINO ACIDS; BINDING SITES; CONSERVED SEQUENCE; HUMANS; MEMBRANE PROTEINS; MUTAGENESIS, SITE-DIRECTED; RECEPTORS, EPOPROSTENOL; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PROSTAGLANDIN;

ANIMALIA;

EID: 3142665410     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0496788     Document Type: Article

References (39)

1. Cheng, Y., et al. (2002) Role of Prostacyclin in the Cardiovascular Response to Thromboxane A2, Science 296, 539-541.
2. Billington, C. K., Penn, R. B. (2003) Signaling and regulation of G protein-coupled receptors in airway smooth muscle, Respir. Res. 4, 2-23.
3. Miggin, S. M., and Kinsella, B. T. (2002) Investigation of the Mechanisms of G Protein: Effector Coupling by the Human and Mouse Prostacyclin Receptors. Identification of Critical Species-Dependent Differences, J. Biol. Chem. 277, 27053-64.
4. Stitham, J., et al. (2003) The Unique Ligand-binding Pocket for the Human Prostacyclin Receptor. Site-Directed Mutagenesis and Molecular Modeling, J. Biol. Chem. 278, 4250-7.
5. Farrens, D. L., et al. (1996) Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin, Science 274, 768-70.
6. Sheikh, S. P., et al. (1996) Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F, Nature 383, 347-50.
7. Sheikh, S. P., et al. (1999) Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation, J. Biol. Chem. 274, 17033-41.
8. Chen, S., et al. (2002) Phe(303) in TMVI of the alpha(1B)-adrenergic receptor is a key residue coupling TM helical movements to G-protein activation, Biochemistry 41, 588-96.
9. Chen, S., et al. (2002) Mutation of a single TMVI residue, Phe(282), in the beta(2)-adrenergic receptor results in structurally distinct activated receptor conformations, Biochemistry 41, 6045-53.
10. Chen, S., et al. (1999) Phe310 in Transmembrane VI of the alpha 1B-Adrenergic Receptor Is a Key Switch Residue Involved in Activation and Catecholamine Ring Aromatic Bonding, J. Biol. Chem. 274, 16320-16330.
11. Roth, B. L., et al. (1998) 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function, Pharmacol. Ther. 79, 231-57.
12. Stitham, J., Martin, K. A., and Hwa, J. (2002) The critical role of transmembrane prolines in human prostacyclin receptor activation, Mol. Pharmacol. 61 (5), 1202-10.
13. Stitham, J., Stojanovic, A., and Hwa, J. (2002) Impaired receptor binding and activation associated with a human prostacyclin receptor polymorphism, J. Biol. Chem. 277, 15439-44.
14. Teller, D. C., et al. (2002) Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs), Biochemistry 40, 7761-72.
15. Guex, N., and Peitsch, M. C. (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling, Electrophoresis 18, 2714-23.
16. Ballesteros, J. A., Weinstein, H. (1995) Integrated Methods for the Construction of Three-Dimensional Models. and Computational Probing of Structure-Function Relations in G Protein-Coupled Receptors, in Receptor Molecular Biology (Sealfon, S., Ed.) pp 366-428, Academic Press, New York.
17. Hwa, J., et al. (1997) Synergism of constitutive activity in alpha 1-adrenergic receptor activation, Biochemistry 36, 633-9.
18. Liu, I. S., et al. (1996) Dopamine D4 receptor variant in Africans, D4valine194glycine, is insensitive to dopamine and clozapine: report of a homozygous individual, Am. J. Med. Genet. 61, 277-82.
19. Miura, S., Zhang, J., and Karnik, S. S. (2000) Angiotensin II type 1 receptor-function affected by mutations in cytoplasmic loop CD, FEBS Lett. 470, 331-5.
20. Noda, K., et al. (1994) The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines, J. Biol. Chem. 269, 6743-52.
21. Neubig, R. R., et al. (2003) International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology, Pharmacol. Rev. 55, 597-606.
22. Ostrom, R. S., Post, S. R., and Insel, P. A. (2000) Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving G(s), J. Pharmacol. Exp. Ther. 294, 407-12.
23. Ostrom, R. S., et al. (2001) Receptor number and caveolar colocalization determine receptor coupling efficiency to adenylyl cyclase, J. Biol. Chem. 276, 42063-9.
24. Altenbach, C., et al. (2001) Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 316 in helix 8 and residues in the sequence 60-75, covering the cytoplasmic end of helices TM1 and TM2 and their connection loop CL1, Biochemistry 40, 15493-500.
25. Altenbach, C., et al. (2001) Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 65 in helix TM1 and residues in the sequence 306-319 at the cytoplasmic end of helix TM7 and in helix H8, Biochemistry 40, 15483-92.
26. Sansom, M. S., and Weinstein, H. (2000) Hinges, swivels and switches: the role of prolines in signalling via transmembrane alpha-helices, Trends Pharmacol. Sci. 21, 445-51.
27. Waugh, D. J., et al. (2000) Novel aromatic residues in transmembrane domains IV and V involved in agonist binding at alpha-(1a)-adrenergic receptors, J. Biol. Chem. 275, 11698-705.
28. McAllister, S. D., et al. (2002) A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognition, Biochem. Pharmacol. 63, 2121-36.
29. Javitch, J. A., et al. (1998) A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice, Biochemistry 37, 998-1006.
30. Altenbach, C., et al. (1996) Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study, Biochemistry 35, 12470-8.
31. Liang, Y., et al. (2003) Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes, J. Biol. Chem. 278, 21655-62.
32. Fotiadis, D., et al. (2003) Atomic-force microscopy: Rhodopsin dimers in native disc membranes, Nature 421, 127-8.
33. Flanagan, C. A., et al. (1999) The functional microdomain in transmembrane helices 2 and 7 regulates expression, activation, and coupling pathways of the gonadotropin-releasing hormone receptor, J. Biol. Chem. 274, 28880-6.
34. Miura, S., et al. (2003) TM2-TM7 interaction in coupling movement of transmembrane helices to activation of the angiotensin II type-1 receptor, J. Biol. Chem. 278, 3720-5.
35. Sealfon, S. C., et al. (1995) Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor, J. Biol. Chem. 270, 16683-8.
36. Wess, J., et al. (1993) Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor, EMBO J. 12, 331-8.
37. Kolakowski, L. F., et al. (1995) Probing the "message: address" sites for chemoattractant binding to the C5a receptor. Mutagenesis of hydrophilic and proline residues within the transmembrane segments, J. Biol. Chem. 270, 18077-82.
38. Fernandez, L. M., and Puett, D. (1996) Identification of amino acid residues in transmembrane helices VI and VII of the lutropin/choriogonadotropin receptor involved in signaling, Biochemistry 35, 3986-93.
39. Hong, S., et al. (1997) Roles of transmembrane prolines and proline-induced kinks of the lutropin/choriogonadotropin receptor, J. Biol. Chem. 272, 4166-71.